EP1425383A4 - STABILIZATION OF CELLS AND BIOLOGICAL PREPARATIONS FOR ANALYSIS - Google Patents
STABILIZATION OF CELLS AND BIOLOGICAL PREPARATIONS FOR ANALYSISInfo
- Publication number
- EP1425383A4 EP1425383A4 EP02768676A EP02768676A EP1425383A4 EP 1425383 A4 EP1425383 A4 EP 1425383A4 EP 02768676 A EP02768676 A EP 02768676A EP 02768676 A EP02768676 A EP 02768676A EP 1425383 A4 EP1425383 A4 EP 1425383A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- analysis
- damage
- cells
- vitro
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
- G01N33/54333—Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
- G01N33/549—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic with antigen or antibody entrapped within the carrier
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31415101P | 2001-08-23 | 2001-08-23 | |
US314151P | 2001-08-23 | ||
US36962802P | 2002-04-03 | 2002-04-03 | |
US369628P | 2002-04-03 | ||
PCT/US2002/026867 WO2003018757A2 (en) | 2001-08-23 | 2002-08-23 | Stabilization of cells and biological specimens for analysis |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1425383A2 EP1425383A2 (en) | 2004-06-09 |
EP1425383A4 true EP1425383A4 (en) | 2005-11-09 |
Family
ID=26979228
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP02768676A Withdrawn EP1425383A4 (en) | 2001-08-23 | 2002-08-23 | STABILIZATION OF CELLS AND BIOLOGICAL PREPARATIONS FOR ANALYSIS |
EP02761478A Expired - Lifetime EP1425294B2 (en) | 2001-08-23 | 2002-08-23 | Analysis of circulating tumor cells, fragments, and debris |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP02761478A Expired - Lifetime EP1425294B2 (en) | 2001-08-23 | 2002-08-23 | Analysis of circulating tumor cells, fragments, and debris |
Country Status (11)
Country | Link |
---|---|
EP (2) | EP1425383A4 (zh) |
JP (3) | JP2005501236A (zh) |
KR (2) | KR20040053115A (zh) |
CN (2) | CN1571634A (zh) |
AT (1) | ATE401574T1 (zh) |
AU (2) | AU2008288601B2 (zh) |
BR (2) | BR0212124A (zh) |
CA (2) | CA2457894C (zh) |
DE (1) | DE60227678D1 (zh) |
IL (2) | IL160209A0 (zh) |
WO (2) | WO2003019141A2 (zh) |
Families Citing this family (94)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1571634A (zh) * | 2001-08-23 | 2005-01-26 | 免疫公司 | 用于分析的细胞和生物学标本的稳定 |
US7863012B2 (en) | 2004-02-17 | 2011-01-04 | Veridex, Llc | Analysis of circulating tumor cells, fragments, and debris |
US8986944B2 (en) | 2001-10-11 | 2015-03-24 | Aviva Biosciences Corporation | Methods and compositions for separating rare cells from fluid samples |
US8980568B2 (en) | 2001-10-11 | 2015-03-17 | Aviva Biosciences Corporation | Methods and compositions for detecting non-hematopoietic cells from a blood sample |
EP1549434A1 (en) | 2002-05-13 | 2005-07-06 | Becton Dickinson and Company | Protease inhibitor sample collection system |
WO2004029221A2 (en) | 2002-09-27 | 2004-04-08 | The General Hospital Corporation | Microfluidic device for cell separation and uses thereof |
CA2445204C (en) | 2002-10-16 | 2014-08-12 | Streck Laboratories, Inc. | Method and device for collecting and preserving cells for analysis |
DE602004030220D1 (de) | 2003-02-27 | 2011-01-05 | Veridex Llc | ZIRKULIERENDE TUMORZELLEN (CTC's): FRÜHE BEURTEILUNG VON TIME-TO-PROGRESSION, ÜBERLEBEN UND ANSPRECHEN AUF THERAPIE BEI PATIENTEN MIT METASTASIERTEM KREBS |
CA2539108A1 (en) * | 2003-09-18 | 2005-03-31 | Immunivest Corporation | Operator independent programmable sample preparation and analysis system |
CA2600225C (en) * | 2005-03-14 | 2016-06-28 | Immunivest Corporation | A method for predicting progression free and overall survival at each follow-up time point during therapy of metastatic breast cancer patients using circulating tumor cells |
US20070196820A1 (en) | 2005-04-05 | 2007-08-23 | Ravi Kapur | Devices and methods for enrichment and alteration of cells and other particles |
DK2500439T4 (da) | 2005-06-20 | 2017-11-13 | Advanced Cell Diagnostics Inc | Kits og produkter til detektering af nukleinsyrer i individuelle celler og til identifikation af sjældne celler fra store heterogene cellepopulationer |
US8921102B2 (en) | 2005-07-29 | 2014-12-30 | Gpb Scientific, Llc | Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
US9424392B2 (en) | 2005-11-26 | 2016-08-23 | Natera, Inc. | System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals |
US8337755B2 (en) | 2006-03-13 | 2012-12-25 | Veridex, Llc | Operator independent programmable sample preparation and analysis system |
PT2027470E (pt) | 2006-06-02 | 2013-01-28 | Pfizer Prod Inc | Ensaio de células tumorais circulantes |
WO2007147074A2 (en) | 2006-06-14 | 2007-12-21 | Living Microsystems, Inc. | Use of highly parallel snp genotyping for fetal diagnosis |
US8372584B2 (en) | 2006-06-14 | 2013-02-12 | The General Hospital Corporation | Rare cell analysis using sample splitting and DNA tags |
US20080050739A1 (en) | 2006-06-14 | 2008-02-28 | Roland Stoughton | Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats |
US8137912B2 (en) | 2006-06-14 | 2012-03-20 | The General Hospital Corporation | Methods for the diagnosis of fetal abnormalities |
CN101583722A (zh) | 2006-07-14 | 2009-11-18 | 阿维瓦生物科学股份有限公司 | 从生物学样品检测稀有细胞的方法和组合物 |
DK2472264T3 (en) * | 2007-02-27 | 2016-02-29 | Sentoclone Internat Ab | Multiplekspåvisning of tumor cells using a panel of agents which bind to extracellular markers |
GB2461476B (en) * | 2007-04-16 | 2012-02-22 | Immunivest Corp | A rapid, semi-automated method to detect respiratory virus infected cells in direct specimens |
US8003314B2 (en) | 2007-04-16 | 2011-08-23 | Diagnostic Hybrids, Inc. | Methods for direct fluorescent antibody virus detection in liquids |
US7828968B2 (en) | 2007-08-30 | 2010-11-09 | Veridex, Llc | Method and apparatus for imaging target components in a biological sample using permanent magnets |
US8110101B2 (en) | 2007-08-30 | 2012-02-07 | Veridex, Llc | Method and apparatus for imaging target components in a biological sample using permanent magnets |
WO2009076560A2 (en) | 2007-12-12 | 2009-06-18 | The Board Of Trustees Of The Leland Stanford Junior University | Method and apparatus for magnetic separation of cells |
CA3069081C (en) | 2008-09-20 | 2023-05-23 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuploidy by sequencing |
US11634747B2 (en) | 2009-01-21 | 2023-04-25 | Streck Llc | Preservation of fetal nucleic acids in maternal plasma |
NO2398912T3 (zh) | 2009-02-18 | 2018-02-10 | ||
WO2011038403A1 (en) | 2009-09-28 | 2011-03-31 | Yuling Luo | Methods of detecting nucleic acid sequences with high specificity |
CN115060882A (zh) | 2009-10-21 | 2022-09-16 | 斯克里普斯研究所 | 用非稀有细胞检测稀有细胞的方法 |
WO2011094669A1 (en) | 2010-01-29 | 2011-08-04 | Advanced Cell Diagnostics, Inc. | Methods of in situ detection of nucleic acids |
WO2011099565A1 (ja) * | 2010-02-10 | 2011-08-18 | シスメックス株式会社 | 血液中癌細胞の検出方法及びそれに用いるプログラム |
US11939634B2 (en) | 2010-05-18 | 2024-03-26 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US10316362B2 (en) | 2010-05-18 | 2019-06-11 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US20190010543A1 (en) | 2010-05-18 | 2019-01-10 | Natera, Inc. | Methods for simultaneous amplification of target loci |
DE102010020785A1 (de) * | 2010-05-18 | 2011-11-24 | Siemens Aktiengesellschaft | Vorrichtung und Verfahren zum Erkennen von magnetisch markierten Mikroobjekten |
US11408031B2 (en) | 2010-05-18 | 2022-08-09 | Natera, Inc. | Methods for non-invasive prenatal paternity testing |
US11332793B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US11326208B2 (en) | 2010-05-18 | 2022-05-10 | Natera, Inc. | Methods for nested PCR amplification of cell-free DNA |
US11332785B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US11322224B2 (en) | 2010-05-18 | 2022-05-03 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US11339429B2 (en) | 2010-05-18 | 2022-05-24 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US9677118B2 (en) | 2014-04-21 | 2017-06-13 | Natera, Inc. | Methods for simultaneous amplification of target loci |
AU2011255641A1 (en) | 2010-05-18 | 2012-12-06 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US20120252038A1 (en) * | 2011-04-01 | 2012-10-04 | Chianese David A | Steroid receptor assays |
WO2012151391A2 (en) | 2011-05-04 | 2012-11-08 | Streck, Inc. | Inactivated virus compositions and methods of preparing such compositions |
US20140295426A1 (en) * | 2011-07-28 | 2014-10-02 | Veridex Llc | Methods for Diagnosing Cancer by Characterization of Tumor Cells Associated with Pleural or Serous Fluids |
US11021733B2 (en) | 2011-09-26 | 2021-06-01 | Qiagen Gmbh | Stabilization and isolation of extracellular nucleic acids |
AU2012314515B2 (en) | 2011-09-26 | 2018-03-15 | Preanalytix Gmbh | Stabilisation and isolation of extracellular nucleic acids |
KR102037891B1 (ko) * | 2012-03-09 | 2019-10-30 | 한국전자통신연구원 | 다중 분리 장치 및 혈중 암세포 분리 방법 |
EP2848935A4 (en) | 2012-05-10 | 2015-12-09 | Konica Minolta Inc | PROCESS FOR REMOVING RED BLOOD BODIES AND CENTRIFUGAL TUBES FOR BLOOD TREATMENT |
ES2614247T3 (es) | 2012-09-25 | 2017-05-30 | Qiagen Gmbh | Estabilización de muestras biológicas |
US20150064153A1 (en) | 2013-03-15 | 2015-03-05 | The Trustees Of Princeton University | High efficiency microfluidic purification of stem cells to improve transplants |
US10324011B2 (en) | 2013-03-15 | 2019-06-18 | The Trustees Of Princeton University | Methods and devices for high throughput purification |
CN105264127B (zh) | 2013-03-15 | 2019-04-09 | Gpb科学有限责任公司 | 颗粒的片上微流体处理 |
EP2976424B1 (en) | 2013-03-18 | 2018-10-03 | Qiagen GmbH | Stabilisation of biological samples |
CN105121643A (zh) * | 2013-03-18 | 2015-12-02 | 凯杰有限公司 | 细胞外核酸的稳定化和分离 |
CA2917912C (en) * | 2013-07-24 | 2019-09-17 | Streck, Inc. | Compositions and methods for stabilizing circulating tumor cells |
CN105899679A (zh) * | 2013-10-21 | 2016-08-24 | 通用医疗公司 | 与循环肿瘤细胞簇有关的方法以及癌症的治疗 |
US10527624B2 (en) | 2014-01-27 | 2020-01-07 | Epic Sciences, Inc. | Circulating tumor cell diagnostics for prostate cancer biomarkers |
US10545151B2 (en) | 2014-02-21 | 2020-01-28 | Epic Sciences, Inc. | Methods for analyzing rare circulating cells |
JP6664332B2 (ja) * | 2014-03-18 | 2020-03-13 | キアゲン ゲーエムベーハー | 細胞外核酸の安定化および単離 |
CN103940997B (zh) * | 2014-03-21 | 2017-01-04 | 上海柏慧康生物科技有限公司 | 一种乳腺癌循环肿瘤细胞检测系统及试剂盒 |
RU2717641C2 (ru) | 2014-04-21 | 2020-03-24 | Натера, Инк. | Обнаружение мутаций и плоидности в хромосомных сегментах |
CN103980365A (zh) * | 2014-06-03 | 2014-08-13 | 国家纳米科学中心 | 一种表面固载炭疽致死因子的磁性纳米粒子、其制备方法及用途 |
EP3164204B1 (en) * | 2014-07-02 | 2021-03-10 | Siemens Healthcare Diagnostics Inc. | Selective nucleic acid separation |
WO2016137915A1 (en) * | 2015-02-24 | 2016-09-01 | Siemens Healthcare Diagnostics Inc. | Prefixation for increased rare cell recovery |
US11168351B2 (en) | 2015-03-05 | 2021-11-09 | Streck, Inc. | Stabilization of nucleic acids in urine |
WO2016183106A1 (en) | 2015-05-11 | 2016-11-17 | Natera, Inc. | Methods and compositions for determining ploidy |
CA2936167A1 (en) * | 2015-07-15 | 2017-01-15 | Streck, Inc. | Method and device for stabilizing of proteins |
JP6617495B2 (ja) * | 2015-09-18 | 2019-12-11 | 東ソー株式会社 | 腫瘍細胞の検出方法 |
WO2017079212A1 (en) * | 2015-11-04 | 2017-05-11 | Axon Dx, Llc | Cell detection, capture, analysis, aggregation, and output methods and apparatus |
US20170145475A1 (en) | 2015-11-20 | 2017-05-25 | Streck, Inc. | Single spin process for blood plasma separation and plasma composition including preservative |
CN108291250B (zh) | 2015-11-20 | 2022-05-27 | 凯杰有限公司 | 用于稳定细胞外核酸的已灭菌组合物的制备方法 |
CN105372109A (zh) * | 2015-12-15 | 2016-03-02 | 苏州药明康德新药开发股份有限公司 | 添加稳定剂的生物基质的制备方法 |
US10945428B2 (en) | 2016-03-04 | 2021-03-16 | Menarini Silicon Biosystems S.P.A. | Preservation of cellular components from cells with a preservative |
US11753682B2 (en) | 2016-03-07 | 2023-09-12 | Father Flanagan's Boys'Home | Noninvasive molecular controls |
JP2017219479A (ja) | 2016-06-09 | 2017-12-14 | 住友電気工業株式会社 | 微小粒子計測装置及び分析方法 |
WO2018022991A1 (en) | 2016-07-29 | 2018-02-01 | Streck, Inc. | Suspension composition for hematology analysis control |
US11485996B2 (en) | 2016-10-04 | 2022-11-01 | Natera, Inc. | Methods for characterizing copy number variation using proximity-litigation sequencing |
US10415080B2 (en) | 2016-11-21 | 2019-09-17 | Nanostring Technologies, Inc. | Chemical compositions and methods of using same |
US10011870B2 (en) | 2016-12-07 | 2018-07-03 | Natera, Inc. | Compositions and methods for identifying nucleic acid molecules |
CA3067946A1 (en) * | 2017-08-02 | 2019-02-07 | Sarstedt Ag & Co. Kg | Process and composition for the stabilization of cell-free nucleic acids and cells |
JP7393328B2 (ja) | 2017-09-01 | 2023-12-06 | ジーピービー・サイエンティフィック・インコーポレイテッド | マイクロ流体を使用した治療的に活性な細胞を調製する方法 |
CN111372451B (zh) * | 2017-10-19 | 2022-08-12 | 斯特雷克股份有限公司 | 用于胞外囊泡的溶血和凝血调节以及稳定化的组合物 |
AU2019271028A1 (en) | 2018-05-14 | 2020-12-03 | Nanostring Technologies, Inc. | Chemical compositions and methods of using same |
JP7334468B2 (ja) * | 2018-05-29 | 2023-08-29 | 東ソー株式会社 | 血液試料保存剤 |
JP7036670B2 (ja) | 2018-05-31 | 2022-03-15 | アークレイ株式会社 | 血液中の稀少細胞検査、該検査ための血液処理方法及び採血管 |
US11525159B2 (en) | 2018-07-03 | 2022-12-13 | Natera, Inc. | Methods for detection of donor-derived cell-free DNA |
CN108865976B (zh) * | 2018-07-19 | 2022-06-28 | 复旦大学附属中山医院 | 一种离散汲取收集外泌体(exosome)的方法及试剂 |
CN110250159A (zh) * | 2019-05-28 | 2019-09-20 | 天津中科生物科技有限公司 | 一种细胞保护液及其制备方法和应用 |
JP7355473B1 (ja) | 2022-03-25 | 2023-10-03 | 積水メディカル株式会社 | 循環腫瘍細胞分離キット、循環腫瘍細胞分離容器及び循環腫瘍細胞の分離方法 |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2475737A1 (fr) * | 1980-02-07 | 1981-08-14 | Pasteur Institut | Perfectionnements apportes aux procedes de conservation d'hematies par lyophilisation en vue de leur utilisation dans des reactions d'hemagglutination et hematies non agglutinables spontanement obtenues par ce procede |
US4404181A (en) * | 1981-10-15 | 1983-09-13 | Cambridge Chemical Products, Inc. | Extended-life tissue fixative composition and method of using the same |
EP0161770A2 (en) * | 1984-05-14 | 1985-11-21 | Becton Dickinson and Company | Lysing agent for analysis of peripheral blood cells |
WO1993005650A1 (en) * | 1991-09-20 | 1993-04-01 | Camiener Gerald W | Methods and compositions with aldehyde stabilizing solution |
WO1994018828A1 (en) * | 1993-02-25 | 1994-09-01 | Abbott Laboratories | Multipurpose reagent system for rapid lysis of whole blood samples |
WO1997008557A1 (en) * | 1995-08-28 | 1997-03-06 | Miltenyi Biotech Gmbh | Efficient enrichment and detection of disseminated tumor cells |
WO1997045729A1 (en) * | 1996-05-24 | 1997-12-04 | Northern General Hospital Nhs Trust | Specimen collection fluid |
US5849517A (en) * | 1991-05-08 | 1998-12-15 | Streck Laboratories, Inc. | Method and composition for preserving antigens and nucleic acids and process for utilizing cytological material produced by same |
US6197523B1 (en) * | 1997-11-24 | 2001-03-06 | Robert A. Levine | Method for the detection, identification, enumeration and confirmation of circulating cancer and/or hematologic progenitor cells in whole blood |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4040785A (en) * | 1976-10-18 | 1977-08-09 | Technicon Instruments Corporation | Lysable blood preservative composition |
US4320111A (en) * | 1977-06-14 | 1982-03-16 | American Home Products Corporation | Immunologic compositions methods of preparation and use |
FR2523810B1 (fr) * | 1982-03-23 | 1988-11-25 | Carpentier Alain | Tissu biologique greffable et procede pour sa preparation |
FR2528848A1 (fr) * | 1982-06-16 | 1983-12-23 | Sanofi Sa | Nouveau derive de thieno-pyridone, son procede de preparation et son application therapeutique |
EP0156537A3 (en) * | 1984-03-02 | 1987-05-13 | Board Of Regents University Of Texas System | Biological magnetic fluids |
US4788139A (en) * | 1987-08-06 | 1988-11-29 | Streck Laboratories, Inc. | Platelet aggregation reagent, reagent container and method of determining platelet aggregation in EDTA-anticoagulated blood |
US5385707A (en) * | 1988-12-28 | 1995-01-31 | Stefan Miltenyi | Metal matrices for use in high gradient magnetic separation of biological materials and method for coating the same |
US5698271A (en) * | 1989-08-22 | 1997-12-16 | Immunivest Corporation | Methods for the manufacture of magnetically responsive particles |
US6670197B2 (en) * | 1997-11-24 | 2003-12-30 | David L. Rimm | Method for assaying whole blood for the presence or absence of circulating cancer or other target cell fragments |
DE69941689D1 (de) * | 1998-02-12 | 2010-01-07 | Univ Texas | Verfahren und reagenzien zur raschen und effizienten isolierung zirkulierender krebszellen |
AU2876900A (en) * | 1999-02-10 | 2000-08-29 | Cell Works Inc. | Class characterization of circulating cancer cells isolated from body fluids andmethods of use |
WO2001019956A2 (en) * | 1999-09-13 | 2001-03-22 | Bander Neil H | A method for isolation of prostatic epithelial cells from semen |
CN1571634A (zh) * | 2001-08-23 | 2005-01-26 | 免疫公司 | 用于分析的细胞和生物学标本的稳定 |
-
2002
- 2002-08-23 CN CNA02820820XA patent/CN1571634A/zh active Pending
- 2002-08-23 KR KR10-2004-7002473A patent/KR20040053115A/ko not_active Application Discontinuation
- 2002-08-23 CA CA2457894A patent/CA2457894C/en not_active Expired - Fee Related
- 2002-08-23 AT AT02761478T patent/ATE401574T1/de not_active IP Right Cessation
- 2002-08-23 IL IL16020902A patent/IL160209A0/xx unknown
- 2002-08-23 BR BR0212124-7A patent/BR0212124A/pt not_active Application Discontinuation
- 2002-08-23 BR BR0212125-5A patent/BR0212125A/pt not_active IP Right Cessation
- 2002-08-23 EP EP02768676A patent/EP1425383A4/en not_active Withdrawn
- 2002-08-23 DE DE60227678T patent/DE60227678D1/de not_active Expired - Lifetime
- 2002-08-23 WO PCT/US2002/026861 patent/WO2003019141A2/en active Application Filing
- 2002-08-23 JP JP2003523608A patent/JP2005501236A/ja active Pending
- 2002-08-23 IL IL16021002A patent/IL160210A0/xx unknown
- 2002-08-23 KR KR10-2004-7002572A patent/KR20040030984A/ko not_active Application Discontinuation
- 2002-08-23 JP JP2003523961A patent/JP2005502863A/ja active Pending
- 2002-08-23 EP EP02761478A patent/EP1425294B2/en not_active Expired - Lifetime
- 2002-08-23 CN CNA028212002A patent/CN1596265A/zh active Pending
- 2002-08-23 CA CA2457891A patent/CA2457891C/en not_active Expired - Fee Related
- 2002-08-23 WO PCT/US2002/026867 patent/WO2003018757A2/en active Application Filing
-
2008
- 2008-12-24 AU AU2008288601A patent/AU2008288601B2/en not_active Ceased
-
2009
- 2009-01-02 AU AU2009200013A patent/AU2009200013B2/en not_active Ceased
- 2009-01-21 JP JP2009011194A patent/JP2009109514A/ja active Pending
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2475737A1 (fr) * | 1980-02-07 | 1981-08-14 | Pasteur Institut | Perfectionnements apportes aux procedes de conservation d'hematies par lyophilisation en vue de leur utilisation dans des reactions d'hemagglutination et hematies non agglutinables spontanement obtenues par ce procede |
US4404181A (en) * | 1981-10-15 | 1983-09-13 | Cambridge Chemical Products, Inc. | Extended-life tissue fixative composition and method of using the same |
EP0161770A2 (en) * | 1984-05-14 | 1985-11-21 | Becton Dickinson and Company | Lysing agent for analysis of peripheral blood cells |
US5849517A (en) * | 1991-05-08 | 1998-12-15 | Streck Laboratories, Inc. | Method and composition for preserving antigens and nucleic acids and process for utilizing cytological material produced by same |
WO1993005650A1 (en) * | 1991-09-20 | 1993-04-01 | Camiener Gerald W | Methods and compositions with aldehyde stabilizing solution |
WO1994018828A1 (en) * | 1993-02-25 | 1994-09-01 | Abbott Laboratories | Multipurpose reagent system for rapid lysis of whole blood samples |
WO1997008557A1 (en) * | 1995-08-28 | 1997-03-06 | Miltenyi Biotech Gmbh | Efficient enrichment and detection of disseminated tumor cells |
WO1997045729A1 (en) * | 1996-05-24 | 1997-12-04 | Northern General Hospital Nhs Trust | Specimen collection fluid |
US6197523B1 (en) * | 1997-11-24 | 2001-03-06 | Robert A. Levine | Method for the detection, identification, enumeration and confirmation of circulating cancer and/or hematologic progenitor cells in whole blood |
Also Published As
Publication number | Publication date |
---|---|
EP1425383A2 (en) | 2004-06-09 |
AU2008288601B2 (en) | 2012-05-31 |
KR20040053115A (ko) | 2004-06-23 |
WO2003019141A3 (en) | 2004-04-01 |
WO2003018757A3 (en) | 2003-09-12 |
IL160210A0 (en) | 2004-07-25 |
CA2457891A1 (en) | 2003-03-06 |
CA2457894C (en) | 2014-07-08 |
CN1571634A (zh) | 2005-01-26 |
CN1596265A (zh) | 2005-03-16 |
BR0212125A (pt) | 2005-06-28 |
BR0212124A (pt) | 2004-07-20 |
JP2005502863A (ja) | 2005-01-27 |
IL160209A0 (en) | 2004-07-25 |
EP1425294A4 (en) | 2005-11-16 |
EP1425294B2 (en) | 2012-12-12 |
WO2003019141A2 (en) | 2003-03-06 |
CA2457894A1 (en) | 2003-03-06 |
EP1425294A2 (en) | 2004-06-09 |
AU2009200013A1 (en) | 2009-02-05 |
JP2009109514A (ja) | 2009-05-21 |
AU2008288601A1 (en) | 2009-04-02 |
CA2457891C (en) | 2019-10-01 |
ATE401574T1 (de) | 2008-08-15 |
EP1425294B1 (en) | 2008-07-16 |
AU2009200013B2 (en) | 2012-03-08 |
KR20040030984A (ko) | 2004-04-09 |
JP2005501236A (ja) | 2005-01-13 |
DE60227678D1 (de) | 2008-08-28 |
WO2003018757A2 (en) | 2003-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL160210A0 (en) | Stabilization of cells and biological specimens for analysis | |
Lazar et al. | Cytometric comparisons between circulating tumor cells from prostate cancer patients and the prostate-tumor-derived LNCaP cell line | |
EP2169387B1 (en) | A high sensivity multiparameter method for rare event analysis in a biological sample | |
NZ333830A (en) | Method for assessing chemosensitivity of a biopsy sample | |
WO2008109414A3 (en) | Use of endogenous fluorescence to identify invading metastatic breast tumor cells | |
Kervarrec et al. | Merkel cell carcinomas infiltrated with CD33+ myeloid cells and CD8+ T cells are associated with improved outcome | |
WO2003106157A3 (en) | AUTOMATIC BLADE COLORING APPARATUS | |
Baker et al. | Rapid cervical cytology screening | |
Subramanian et al. | Significance of bone marrow fibrosis in multiple myeloma | |
Teman et al. | Quantification of fibrosis and osteosclerosis in myeloproliferative neoplasms: a computer-assisted image study | |
WO2003023354A3 (en) | Optical bio-disc systems for nuclear morphology based identification | |
Pijanka et al. | Spectroscopic signatures of single, isolated cancer cell nuclei using synchrotron infrared microscopy | |
Cattan et al. | Circulating gastrin, endocrine cells, histamine content, and histidine decarboxylase activity in atrophic gastritis | |
Böttger et al. | DNA image cytometry. A prognostic tool in squamous cell carcinoma of the esophagus? | |
Simons et al. | Effects of histological staining on the analysis of human DNA from archived slides | |
Gong et al. | Clonal status and clinicopathological features of Langerhans cell histiocytosis | |
Woolman et al. | Rapid determination of the tumour stroma ratio in squamous cell carcinomas with desorption electrospray ionization mass spectrometry (DESI-MS): a proof-of-concept demonstration | |
Zver et al. | Minimal residual disease detection in cryopreserved ovarian tissue by multicolor flow cytometry in acute myeloid leukemia | |
WO2011033290A3 (en) | Dual fluorescence assay for determining viability of parasitic or non- parasitic worms | |
Toman | What are the advantages and disadvantages of fluorescence microscopy | |
Zver et al. | Validation of an automated technique for ovarian cortex dissociation: isolation of viable ovarian cells and their qualification by multicolor flow cytometry | |
Shen et al. | Accurate and noninvasive embryos screening during in vitro fertilization (IVF) assisted by Raman analysis ofembryos culture medium | |
Balasubramanian et al. | Isolation and characterization of circulating tumor cells (CTCs) from peripheral blood specimens of patients with advanced solid tumor malignancies (using ApoStream (TM) instrumentation) | |
Zickuhr et al. | Spatial Metabolomics co-registered with Multiplex Phenotyping for the Evaluation of Human Kidney Tissue | |
Dao et al. | Using micro-synchrotron radiation x-ray fluorescence (µ-SRXRF) for trace metal imaging in the development of MRI contrast agents for prostate cancer imaging |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20040315 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7A 01N 1/02 A |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20050927 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7A 01N 1/02 B Ipc: 7G 01N 33/574 B Ipc: 7G 01N 33/543 A |
|
17Q | First examination report despatched |
Effective date: 20060623 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20080508 |